The STAT3 pathway has been identified as a potential target for many cancers, including cervical cancer, lymphomas, hepatocellular carcinoma, multiple myeloma tumours, and leukemia, (Bowman et al., 2000). This evidence concerns the gene STAT3 and cervical cancer.